[A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. (NCI04) ( NCI )]
UMLS (NCI) C0796336VHL Peptides
Von Hippel-Lindau Peptide Vaccine
- Amino Acid, Peptide, or Protein
- Pharmacologic Substance
- Immunologic Factor